Published by Coherent Market Insights
Posted on October 1, 2021
4 min readLast updated: February 1, 2026
The emergence of Covid-19 is boosting the seasonal influenza vaccines market, with key players like Sanofi and GlaxoSmithKline leading the growth.
Seasonal influenza is caused by viruses known as influenza A, B, C, and D. These names refer to the four types of viruses, and each has a different way of entering the human body. For example, an A virus can be transmitted through the air, while B is most often transmitted through secretions from the nose or mouth. C is the most commonly caught form of the disease but does not usually spread from person to person. Influenza A viruses are the only influenza viruses known to cause flu pandemics, i.e., global epidemics of flu disease.
Request Sample Copy of This Report @
https://www.coherentmarketinsights.com/insight/request-sample/1604
High prevalence of acute respiratory infections is expected to propel growth of the seasonal influenza vaccines market. For instance, the study, ‘Viral and Bacterial Etiologies of Acute Respiratory Infections among Children under 5 Years in Senegal’, published in the journal Microbiology Insights, in February 2018, found that adenovirus was the most prevalent (50%) among selected virus species, followed by influenza virus, rhinovirus, enterovirus, and respiratory syncytial virus.
Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the seasonal influenza vaccines market. For instance, globally, as of 4:25pm CET, 2 December 2020, there have been 63,360,234 confirmed cases of COVID-19, including 1,475,825 deaths, reported to the World Health Organization. Moreover, many people are getting flu shots along with COVID testing, which is also expected to aid in growth of the market. For instance, in December 2020, Tarrant County, TX, U.S., partnered with pharmacies at Kroger and Tom Thumb to help provide free flu vaccines for uninsured residents.
Moreover, increasing awareness about flu is also expected to aid in growth of the seasonal influenza vaccines market. For instance, in September 2019, the Wisconsin Department of Health Services (DHS) announced a new community outreach and education funding opportunity for community organizations in order to increase awareness about the flu and the number of Wisconsinites getting flu vaccines.
Major Players in Seasonal Influenza Vaccines Market
Sanofi S.A., CSL Limited, GlaxoSmithKline Plc., and Medimmune, LLC. Key players in the market are involved in strategic mergers and acquisitions, to cater to increasing demand for these vaccines.
Ask for PDF sample copy of the Seasonal Influenza Vaccines market report @
https://www.coherentmarketinsights.com/insight/request-pdf/1604
Why this is Important Report to you? It helps:
• To analyze and study the Global Seasonal Influenza Vaccines Market capacity, production, value, consumption, status Focuses on the Key Seasonal Influenza Vaccines manufacturers, to study the capacity, production, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application, and region.
• To analyze the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
• To identify significant trends and factors driving or inhibiting market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the Seasonal Influenza Vaccines Market.
• To strategically profile the key players and comprehensively analyze their growth strategies.
• It provides a forward-looking perspective on different factors driving or restraining Market growth.
• It provides a six-year forecast assessed on the basis of how the Market is predicted to grow.
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors.
• It helps in making informed business decisions by having complete insights and by making an in-depth analysis of Market segment
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/1604
In conclusion, the Seasonal Influenza Vaccines market report presents the descriptive analysis of the parent market supported elite players, present, past, and artistic movement information which is in a position to function as a profitable guide for all the Seasonal Influenza Vaccines industry business competitors. Our expert research analyst’s team has been trained to supply in-depth marketing research reports from every individual sector which can be helpful to know the industry data within the most precise way.
Contact:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Seasonal Influenza Vaccines Market Emergence of Covid-19 to Augment Growth | Sanofi S.A., CSL Limited, GlaxoSmithKline and Medimmune, LLC appeared first on Gatorledger.
The article discusses the growth of the seasonal influenza vaccines market amid the Covid-19 pandemic.
Covid-19 is increasing demand for flu vaccines as people seek protection from respiratory infections.
Major companies include Sanofi S.A., CSL Limited, GlaxoSmithKline, and Medimmune, LLC.
Explore more articles in the Research Reports category
